Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment ...Middle East

PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics ("GEMMABio") commented on Solid Bioscience's announcement of clearance by the Food and Drug Administration for its Investigational New Drug (IND) to treat Friedreich's ataxia (FA):...

Hence then, the article about gene therapy pioneer jim wilson comments on solid biosciences s announcement of fda ind clearance for friedreich s ataxia treatment was published today ( Wednesday 08/01/2025 - 10:50 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment )

Also on site :

• LIVE: Iran announces live-fire naval drills near US warships amid tensions
• '70s Music Icon Receives Major Grammy Honor Nearly Three Decades After His Death
• 'The Pitt': What Is Worse Than MRSA? Dr. Langdon's Latest Patient Diagnosis, Explained